We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
| Level: | Consumer |
|---|---|
| Class: | I |
| Reference: | R2005/1313 |
| Date agreed: | 07 October 2005 |
| Product: | DUROGESIC® 50 microgram/h fentanyl transdermal patches |
| ARTG number: | AUST R 60595 |
| Batch number: | 5CB2P00 & 5DB3D00 |
| Sponsor: | Janssen-Cilag Pty Ltd |
| Contact: | 1300 369 949 Medical Information Centre |
| Reason: | A small number of units from this batch could have incomplete sealing, which could allow some of the medication (a gel) inside the patch to leak out. |
Recall letters were dispatched on 6 October 2005.
Please Note - Patients are being contacted directly by mail rather than through the use of press advertising.
Classification system:
Class I defects are potentially life-threatening or could cause a serious risk to health.
Class II defects could cause illness or mistreatment, but are not Class I.
Class III defects may not pose a significant hazard to health, but withdrawal may be initiated for other reasons.
Class I & II recalls are considered to be safety related recalls.